Investors

Welcome to the Mendus investor page. Mendus is listed on NASDAQ Stockholm under the ticker symbol IMMU.
Letter from the CEO
“Establishing a late-stage clinical development company”
To read the latest CEO comment, please click here.
Contact
Telephone
+46 (0)8 732 8400
info@mendus.com

Head Office
Västra Trädgårdsgatan 15
111 53 Stockholm
Sweden

R&D Offices
Emmy Noetherweg 2K
2333 BK Leiden
The Netherlands

Gothenburg Office
Mendus C/O AstraZeneca BioventureHub
Pepparedsleden 1
431 83 Mölndal
Sweden
